NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘ARCH Venture Partners’

16 June 2015

Arch leads $30m in Aledade alongside return investor Venrock

spire healthcare Arch Venture Partners has led $30m Series B financing round in Aledade, a US company which looks to help doctors run small practices.

15 May 2015

Degenerative brain disease treatment company Denali launched with $217m VC backing

brain-001-880737-m A group of venture capital investors have helped launch degenerative brain disease treatment company Denali Therapeutics through a $217m investment.

15 April 2015

Company helping synthesise human vision nets $40m VC-backed funding round

eye A joint venture between Atlantic Bridge Capital and WestSummit Capital has led a $40m financing round for a tech business which aims to help companies implement visual sensing to mimic human sight.

12 March 2015

Kura Oncology closes $60m EcoR1 Capital-led round

download (76) EcoR1 Capital has led a $60m financing round in biopharmaceutical company in Kura Oncology.

22 December 2014

VC-backed Juno Therapeutics raises $264.5m at IPO

money-in-hand-1035691-m Arch Venture Partners-backed cancer fighting company Juno Therapeutics has raised $264.5m after pricing its shares at $24m.

28 October 2014

Syros lands $53m from eight VC firms

pills-pills-pills-4-606633-m Eight venture capital firms have participated in a $53m Series B financing round for gene control therapies company Syros Pharmaceuticals.

27 August 2014

Arch Venture Partners raises more than $400m for latest fund

chicagooo Chicago-based venture capital firm Arch Venture Partners has closed its eighth fund on more than $400m, easily beating its $250m target.

7 August 2014

Venture capital-backed Juno Therapeutics raises $134m Series B

cancer juno Venture capital-backed biotechnology startup Juno Therapeutics has raised $134m in its Series B round to fund the development of its immunotherapies for cancer.

29 July 2014

Accelerator holds $51.1m first close for life science venture capital Fund IV

news_dollars3_lrg Biotech venture capital firm Accelerator Corporation has announced a $51.1m first closing of its fourth fund.

27 May 2014

Tao Invest leads Twist Bioscience’s $26m Series B

twist San Francisco-based synthetic DNA producer Twist Bioscience has secured $26m in a Series B round led by Tao Invest.

Page 1 of 212

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015